Solid vaccine formulation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/35 (2006.01) A61K 9/00 (2006.01)

Patent

CA 2624503

The invention relates to a solid vaccine formulation adapted for mucosal administration comprising at least one antigen as active substance, wherein the formulation comprises a lyophilisate of a suspension comprising an oxygen- containing metal salt, the antigen(s) and one or more excipients selected from (i) saccharides, (ii) sugar alcohols, and (iii) amino acids or pharmaceutically acceptable salts thereof.

La présente invention concerne une formulation vaccinale solide convenant pour une administration par voie muqueuse, comprenant au moins un antigène comme substance active. Ladite formulation comprend un lyophilisat d~une suspension comprenant un sel métallique contenant de l~oxygène, l~antigène(s) ainsi qu~un ou des excipients sélectionnés à partir de (i) saccharides, (ii) polyols, ainsi que (iii) des acides aminés ou sels pharmaceutiquement acceptables de ceux-ci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Solid vaccine formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Solid vaccine formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solid vaccine formulation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1436022

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.